Concepedia

Monitoring Recombinant Factor VIIa Treatment: Efficacy Depends on High Levels of Fibrinogen in a Model of Severe Dilutional Coagulopathy

Michael T. Ganter, Saskia Schmuck, Christine Hamiel, Paul E. Wischmeyer, Daniela Heule, Andreas Zollinger, Christoph K. Hofer

Journal of Cardiothoracic and Vascular Anesthesia · 2008 · 23 citations · 24 references

DOI

Concepts

References

24

Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials

Kenneth D Boffard, Bruno Riou, Brian Warren et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2005 · 785 citations

, , +16

Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa

Kathryn A. O’Connell · JAMA · 2006 · 673 citations

, , +17

Hemostatic Factors and Replacement of Major Blood Loss with Plasma-Poor Red Cell Concentrates

Seppo Hiippala, G. Myllylä, Elina Vahtera · Anesthesia & Analgesia · 1995 · 659 citations

, , +17

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

Jean‐Louis Vincent, Rolf Rossaint, Bruno Riou et al. · Critical Care · 2006 · 384 citations · Full text

, , +8

Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation

Benny Sørensen, Peter Johansen, K. Christiansen et al. · Journal of Thrombosis and Haemostasis · 2003 · 353 citations · Full text

, , +13